Clinical Trial Update: Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial [Phase 2]

View source ↗

Summary

This clinical trial update outlines the Phase 2 FORMaT adaptive platform trial evaluating a novel combination treatment (Arm D) versus standard of care for inte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Abscessus Infection
• Mycobacterium Abscessus Pulmonary Disease
• Non-tuberculous Mycobacterial Infections
• Non-tuberculous Mycobacterial Pulmonary Disease

Snippet

Sponsor: The University of Queensland | Conditions: Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection | Phase 2 | Status: NOT_YET_RECRUITING